Post-Organon deal, ICICI Direct downgraded Sun Pharma to Hold, IIFL adjusted to Add, Investec maintained a Sell rating, while ...

(Bloomberg) -- Sun Pharmaceutical Industries Ltd. has agreed to acquire New York-listed women’s health-care company Organon & Co., expanding its global reach with one of the biggest outbound deals by ...

Shares of Organon OGN jumped 16% in pre-market trading after the company and India’s Sun Pharmaceutical Industries Limited jointly announced a definitive agreement. Per the agreement, Sun Pharma will ...

April 26 (Reuters) - Sun Pharmaceutical Industries will buy U.S. drugmaker Organon & Co in an all-cash deal valued at about $11.75 billion ‌including debt, for the largest overseas acquisition by an ...

Sun Pharmaceutical Industries Ltd’s proposed acquisition of US-based Organon & Co for an enterprise value of ₹11.75 billion marks the largest-ever overseas acquisition in the pharma sector by an ...

After intense negotiations, Sun Pharma is set to acquire Organon for $11.75 billion, marking a significant milestone for Indian overseas acquisitions. The deal aims to strengthen Sun Pharma's global ...

Explore major outbound acquisitions by Indian companies, including Sun Pharma, Tata Steel, Bharti Airtel, and Hindalco. Details on deal values and impact.

The S&P 500 Index ($SPX) (SPY) today is down -0.12%, the Dow Jones Industrial Average ($DOWI) (DIA) is down -0.14%, and the Nasdaq 100 Index ($IUXX) (QQQ) is down -0.30%. June E-mini S&P futures ...

Stocks held at record highs before a raft of megacap earnings that will test whether April’s rally is sustainable, with ...

Global lenders to Sun Pharmaceutical Industries Ltd. are weighing multiple financing options for its proposed $12 billion ...

MUMBAI, India & JERSEY CITY, N.J.--(BUSINESS WIRE)--Sun Pharmaceutical Industries Limited (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715) (together with its subsidiaries and/or ...